FN1 and non-small cell lung carcinoma: Clinically, FN expression has been identified as one of the prognostic biomarkers in CTCs of non-small cell lung cancer (NSCLC), gastric cancer, invasive breast cancer, and pancreatic cancer patients [45,56,57,58].